In the inevitable situation where we cannot advance our business at home and abroad during the COVID-19 period, we have been relaxed since this month and our business is actively progressing at home and abroad.

During the same period, Anyfusion was upgraded to provide 96 hours of real-time accuracy, and the air alarm stress caused by the limitation of the original technology of the existing drug injection pump due to the occurrence of air alarm once or twice.

The U.S. major company, which sells the most pumps, is developing and promoting a device that collects air in the pump to remove the air alarm from the existing pump, and also minimizes the alarm stress with a separate syringe.

Most buyers, including the U.S., who shared information that minimized air alarms for 96 hours through this upgrade, are asking for FDA 510K certification and visit to sell their highly praised products in their country.

Anyfusion, a cylinder pump, has many needs for medicine injection and cancer-containing (injection) preparation, as well as PCA balloon is filled with needles by nurses or pharmacists, and as the amount of filling increases, there are more needs for medical accidents such as pain in the wrist and syringe stabbing.

I shared that information both at home and abroad.

With this information, companies that manufacture PCA balloon and overseas buyers have doubled the need and importance of Anyfusion.

In addition, the Anyfusion demo was used for quantitative, precise, and accurate injection of boron, an essential drug for cancer treatment with neutron accelerator, and the range of Anyfusion use was strategically expanded and sales are underway.

In particular, the U.S. buyer has repeatedly demanded FDA 510K certification, which requires a lot of cost and time, by giving work load-less and various functions and performance such as above to Anyfusion's Infection-less, Syringe-less, and Airless.

Under the premise of rapid FDA510K certification, the U.S., CE-certified Spain, and SFDA-certified Saudi Arabia are pushing for exclusive supply of Ayfusion, and large medical markets Japan and Germany are also sharing performance with the real world reference on the premise of the contract.

Anyfusion ACPi requires the development of related equipment and programs in cartridges that are three to four times faster than the existing cartridges.

We confirmed that the market needs a lot of general-purpose anticancer drug preparation equipment with high cost-effectiveness compared to robots.

We would like to proceed based on the Anyfusion contract and sales trend.

Anyfusion's accumulated reference and performance optimized for the U.S. medical market, which is the largest medical advanced country, is expected to sign meaningful contracts of up to hundreds of billions of won, including major U.S. companies, and Spain and Saudi Arabia, in the first half or July-August.

Thank you.